MARKETS / BALCAO / PBSV

BALCAO · SERVICES-MANAGEMENT CONSULTING SERVICES · SMALL CAP

Pharma-Bio Serv, Inc. PBSV

16 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$9.0M

▼ 5.3% YoY

Net income

$-100,463

Free cash flow

$-221,530

In brief

What this company does

The Company operates in Puerto Rico, the United States, Europe and Brazil under the name of Pharma-Bio Serv, and is engaged in providing technical compliance consulting services to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. We are a regulatory affairs, quality, compliance and technology transfer services consulting firm with headquarters in Puerto Rico, servicing the Puerto Rico, United States and European markets, and to a lesser extent the Brazilian market. We provide a broad range of compliance-related consulting services. We market our services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies principally in Puerto Rico, the United States, Europe and Brazil. We seek opportunities in markets that can yield profitable margins using our professional consulting force.

Written from the business description in Pharma-Bio Serv, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 29 January 2026. Every sentence was checked against that document before publication.

Growth

USD 9.0M

Revenue, FY2025 · full 16-year series below

Revenue $M Net income $M

FY2025 · Revenue 9.0 · Net income -0.1

Compound annual growth

Revenue

−22.6%

−16.0%

−9.1%

−1.5%

Returned to shareholders

−20.8%

+0.3%

+26.4%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at −16.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−1 cents

lost on every revenue dollar

Operating margin Net margin

FY2025 · Operating -7.1% · Net -1.1%

ROE

FY2025 · ROE -0.8%

Gross margin32.3%

Operating margin-7.1%

Net margin-1.1%

Return on assets-0.7%

EBITDA—

Each USD of equity lost 1 cents this year.

Cash & shareholders

USD 1.8M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF -0.2

Net buybacks $M Dividends $M

FY2025 · Dividends 1.7 · Net buybacks 0.0

Dividends paidUSD 1.7M

Net buybacksUSD 31,443.00

Share of profit-1743.3%

Consecutive raises—

USD 1.7M in dividends and USD 31,443.00 in buybacks went back to shareholders in a year without profit.

Total assetsUSD 13.7M

EquityUSD 11.9M

CashUSD 3.4M

Current ratio7.70×

Equity funds 87% of total assets.

The 16-year record

16 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Revenue $B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Operating income $B	−0.0	−0.0	0.0	0.0	−0.0	0.0	0.0	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBITDA $B	·	·	·	0.0	−0.0	0.0	0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Income tax $B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income $B	−0.0	−0.0	0.0	0.0	−0.0	0.0	0.0	0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0
Free cash flow $B	−0.0	−0.0	0.0	0.0	0.0	0.0	−0.0	0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPS, diluted $	−0.00	−0.03	0.06	·	·	0.09	0.09	·	−0.06	−0.01	0.07	0.10	0.21	0.20	0.14	0.02
Dividend / sh $	·	·	·	·	·	·	0.07	·	·	·	·	·	·	·	·	·
Payout %	−1712	−221	132	342	−83	84	0	·	·	·	·	·	·	·	·	·
ROE %	−0.8	−5.2	8.0	5.7	−10.0	9.5	10.2	6.2	−6.6	−1.2	7.7	12.5	31.7	44.4	47.5	7.3
Shares out B	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 77 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 18 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityServices-Management Consulting Services

Listed onOTC market

Incorporated innot stated in the filings

Fiscal year endsOctober 31

SEC categorysmaller reporting company

Data on record since2010